Trexquant Investment LP acquired a new position in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 36,657 shares of the semiconductor company's stock, valued at approximately $17,792,000.
Several other hedge funds and other institutional investors also recently modified their holdings of SNPS. Kieckhefer Group LLC bought a new position in Synopsys during the fourth quarter valued at about $27,000. Whipplewood Advisors LLC acquired a new position in shares of Synopsys in the 4th quarter worth approximately $33,000. Sierra Ocean LLC bought a new stake in shares of Synopsys in the 4th quarter worth approximately $39,000. Hazlett Burt & Watson Inc. lifted its position in shares of Synopsys by 28.6% during the 4th quarter. Hazlett Burt & Watson Inc. now owns 90 shares of the semiconductor company's stock valued at $44,000 after acquiring an additional 20 shares during the last quarter. Finally, Newbridge Financial Services Group Inc. acquired a new position in shares of Synopsys in the 4th quarter worth $51,000. Institutional investors own 85.47% of the company's stock.
Insider Transactions at Synopsys
In other Synopsys news, CRO Richard S. Mahoney sold 20,838 shares of the business's stock in a transaction dated Wednesday, January 15th. The shares were sold at an average price of $506.01, for a total value of $10,544,236.38. Following the transaction, the executive now directly owns 1,460 shares in the company, valued at $738,774.60. The trade was a 93.45 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Sassine Ghazi sold 11,366 shares of the business's stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $463.75, for a total transaction of $5,270,982.50. Following the completion of the sale, the chief executive officer now directly owns 70,922 shares in the company, valued at approximately $32,890,077.50. This trade represents a 13.81 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 47,909 shares of company stock worth $22,794,835. Company insiders own 0.62% of the company's stock.
Synopsys Trading Down 7.1 %
NASDAQ SNPS traded down $29.63 during trading on Friday, hitting $388.13. 2,513,019 shares of the company's stock were exchanged, compared to its average volume of 1,065,266. The company has a market cap of $60.01 billion, a PE ratio of 26.73, a P/E/G ratio of 3.23 and a beta of 1.23. Synopsys, Inc. has a fifty-two week low of $387.41 and a fifty-two week high of $624.80. The stock's 50 day moving average price is $473.83 and its two-hundred day moving average price is $503.09.
Analysts Set New Price Targets
A number of equities research analysts have recently issued reports on SNPS shares. Morgan Stanley cut their price target on shares of Synopsys from $625.00 to $590.00 and set an "overweight" rating on the stock in a report on Monday, February 24th. Redburn Atlantic started coverage on Synopsys in a research report on Monday, January 13th. They set a "buy" rating and a $600.00 price objective for the company. Rosenblatt Securities reiterated a "buy" rating and issued a $660.00 price objective on shares of Synopsys in a research note on Tuesday, February 25th. Wells Fargo & Company cut their price objective on Synopsys from $540.00 to $520.00 and set an "equal weight" rating for the company in a report on Thursday, February 27th. Finally, Needham & Company LLC restated a "buy" rating and issued a $650.00 target price on shares of Synopsys in a research note on Thursday, February 27th. One equities research analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Synopsys presently has an average rating of "Moderate Buy" and a consensus target price of $638.58.
Get Our Latest Research Report on Synopsys
Synopsys Profile
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Further Reading

Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.